January 25th 2024
The expanded indication makes dupilumab the only approved treatment for eosinophilic esophagitis (EoE) in this age group.
Defining the recommended guidelines and the formulary restrictions with the standard of care for asthma.
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
Success in Eosinophil-Targeted Treatments for EoE Remains Limited
Bradykinin Level Displays Biomarker Benefit in Nasal Polyposis
Researchers Advocate for Closer Monitoring of Patients With EoE